<?xml version="1.0" encoding="UTF-8"?>
<p id="par0400">
 <list list-type="simple" id="lis0050">
  <list-item id="lsti0125">
   <label>â€¢</label>
   <p id="par0405">The complex process by which poxviruses exit cells has provided targets for antiviral therapy. The small-molecule ST-246 interacts specifically with the vaccinia virus F13L protein, which is involved in the addition of a membrane layer needed to form extracellular enveloped virions (
    <xref rid="bib0515" ref-type="bibr">Yang et al., 2005</xref>, 
    <xref rid="bib0195" ref-type="bibr">Duraffour et al., 2008</xref>). ST-246 is nontoxic for mammalian cells, animals and humans, suggesting that it uniquely targets the viral enzyme, and could therefore be used as a radiolabeled probe to image poxvirus infections.
   </p>
  </list-item>
 </list>
</p>
